1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Bile Duct Cancer Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 5-fluorouracil 1.2.3 Gemcitabine 1.2.4 Cisplatin 1.2.5 Other 1.3 Market by Application 1.3.1 Global Bile Duct Cancer Market Growth Rate by Application: 2017 VS 2021 VS 2028 1.3.2 Hospitals & Clinics 1.3.3 Other 1.4 Study Objectives 1.5 Years Considered 2 Market Perspective 2.1 Global Bile Duct Cancer Market Size (2017-2028) 2.2 Bile Duct Cancer Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028 2.3 Global Bile Duct Cancer Market Size by Region (2017-2022) 2.4 Global Bile Duct Cancer Market Size Forecast by Region (2023-2028) 2.5 Global Top Bile Duct Cancer Countries Ranking by Market Size 3 Bile Duct Cancer Competitive by Company 3.1 Global Bile Duct Cancer Revenue by Players 3.1.1 Global Bile Duct Cancer Revenue by Players (2017-2022) 3.1.2 Global Bile Duct Cancer Market Share by Players (2017-2022) 3.2 Global Bile Duct Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Company Covered: Ranking by Bile Duct Cancer Revenue 3.4 Global Bile Duct Cancer Market Concentration Ratio 3.4.1 Global Bile Duct Cancer Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Bile Duct Cancer Revenue in 2021 3.5 Global Bile Duct Cancer Key Players Head office and Area Served 3.6 Key Players Bile Duct Cancer Product Solution and Service 3.7 Date of Enter into Bile Duct Cancer Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Global Bile Duct Cancer Breakdown Data by Type 4.1 Global Bile Duct Cancer Historic Revenue by Type (2017-2022) 4.2 Global Bile Duct Cancer Forecasted Revenue by Type (2023-2028) 5 Global Bile Duct Cancer Breakdown Data by Application 5.1 Global Bile Duct Cancer Historic Market Size by Application (2017-2022) 5.2 Global Bile Duct Cancer Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Bile Duct Cancer Revenue by Company (2020-2022) 6.2 North America Bile Duct Cancer Revenue by Type (2017-2028) 6.3 North America Bile Duct Cancer Revenue by Application (2017-2028) 6.4 North America Bile Duct Cancer Revenue by Country (2017-2028) 6.4.1 U.S. 6.4.2 Canada 7 Europe 7.1 Europe Bile Duct Cancer Revenue by Company (2020-2022) 7.2 Europe Bile Duct Cancer Revenue by Type (2017-2028) 7.3 Europe Bile Duct Cancer Revenue by Application (2017-2028) 7.4 Europe Bile Duct Cancer Revenue by Country (2017-2028) 7.4.1 Germany 7.4.2 France 7.4.3 U.K. 7.4.4 Italy 7.4.5 Russia 8 Asia Pacific 8.1 Asia Pacific Bile Duct Cancer Revenue by Company (2020-2022) 8.2 Asia Pacific Bile Duct Cancer Revenue by Type (2017-2028) 8.3 Asia Pacific Bile Duct Cancer Revenue by Application (2017-2028) 8.4 Asia Pacific Bile Duct Cancer Revenue by Region (2017-2028) 8.4.1 China 8.4.2 Japan 8.4.3 South Korea 8.4.4 India 8.4.5 Australia 8.4.6 Taiwan 8.4.7 Indonesia 8.4.8 Thailand 8.4.9 Malaysia 8.4.10 Philippines 8.4.11 Vietnam 9 Latin America 9.1 Latin America Bile Duct Cancer Revenue by Company (2020-2022) 9.2 Latin America Bile Duct Cancer Revenue by Type (2017-2028) 9.3 Latin America Bile Duct Cancer Revenue by Application (2017-2028) 9.4 Latin America Bile Duct Cancer Revenue by Country (2017-2028) 9.4.1 Mexico 9.4.2 Brazil 9.4.3 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Bile Duct Cancer Revenue by Company (2020-2022) 10.2 Middle East and Africa Bile Duct Cancer Revenue by Type (2017-2028) 10.3 Middle East and Africa Bile Duct Cancer Revenue by Application (2017-2028) 10.4 Middle East and Africa Bile Duct Cancer Revenue by Country (2017-2028) 10.4.1 Turkey 10.4.2 Saudi Arabia 10.4.3 U.A.E 11 Company Profiles 11.1 Pfizer 11.1.1 Pfizer Company Details 11.1.2 Pfizer Business Overview 11.1.3 Pfizer Bile Duct Cancer Products and Services 11.1.4 Pfizer Bile Duct Cancer Revenue in Bile Duct Cancer Business (2017-2022) 11.1.5 Pfizer Bile Duct Cancer SWOT Analysis 11.1.6 Pfizer Recent Developments 11.2 F. Hoffmann-La Roche 11.2.1 F. Hoffmann-La Roche Company Details 11.2.2 F. Hoffmann-La Roche Business Overview 11.2.3 F. Hoffmann-La Roche Bile Duct Cancer Products and Services 11.2.4 F. Hoffmann-La Roche Bile Duct Cancer Revenue in Bile Duct Cancer Business (2017-2022) 11.2.5 F. Hoffmann-La Roche Bile Duct Cancer SWOT Analysis 11.2.6 F. Hoffmann-La Roche Recent Developments 11.3 Bristol-Myers Squibb 11.3.1 Bristol-Myers Squibb Company Details 11.3.2 Bristol-Myers Squibb Business Overview 11.3.3 Bristol-Myers Squibb Bile Duct Cancer Products and Services 11.3.4 Bristol-Myers Squibb Bile Duct Cancer Revenue in Bile Duct Cancer Business (2017-2022) 11.3.5 Bristol-Myers Squibb Bile Duct Cancer SWOT Analysis 11.3.6 Bristol-Myers Squibb Recent Developments 11.4 Teva Pharmaceutical 11.4.1 Teva Pharmaceutical Company Details 11.4.2 Teva Pharmaceutical Business Overview 11.4.3 Teva Pharmaceutical Bile Duct Cancer Products and Services 11.4.4 Teva Pharmaceutical Bile Duct Cancer Revenue in Bile Duct Cancer Business (2017-2022) 11.4.5 Teva Pharmaceutical Bile Duct Cancer SWOT Analysis 11.4.6 Teva Pharmaceutical Recent Developments 11.5 Eli Lilly and Company 11.5.1 Eli Lilly and Company Company Details 11.5.2 Eli Lilly and Company Business Overview 11.5.3 Eli Lilly and Company Bile Duct Cancer Products and Services 11.5.4 Eli Lilly and Company Bile Duct Cancer Revenue in Bile Duct Cancer Business (2017-2022) 11.5.5 Eli Lilly and Company Bile Duct Cancer SWOT Analysis 11.5.6 Eli Lilly and Company Recent Developments 11.6 Sanofi 11.6.1 Sanofi Company Details 11.6.2 Sanofi Business Overview 11.6.3 Sanofi Bile Duct Cancer Products and Services 11.6.4 Sanofi Bile Duct Cancer Revenue in Bile Duct Cancer Business (2017-2022) 11.6.5 Sanofi Bile Duct Cancer SWOT Analysis 11.6.6 Sanofi Recent Developments 11.7 Fresenius Kabi 11.7.1 Fresenius Kabi Company Details 11.7.2 Fresenius Kabi Business Overview 11.7.3 Fresenius Kabi Bile Duct Cancer Products and Services 11.7.4 Fresenius Kabi Bile Duct Cancer Revenue in Bile Duct Cancer Business (2017-2022) 11.7.5 Fresenius Kabi Bile Duct Cancer SWOT Analysis 11.7.6 Fresenius Kabi Recent Developments 11.8 Mylan 11.8.1 Mylan Company Details 11.8.2 Mylan Business Overview 11.8.3 Mylan Bile Duct Cancer Products and Services 11.8.4 Mylan Bile Duct Cancer Revenue in Bile Duct Cancer Business (2017-2022) 11.8.5 Mylan Bile Duct Cancer SWOT Analysis 11.8.6 Mylan Recent Developments 12 Bile Duct Cancer Market Dynamics 12.1 Bile Duct Cancer Market Trends 12.2 Bile Duct Cancer Market Drivers 12.3 Bile Duct Cancer Market Challenges 12.4 Bile Duct Cancer Market Restraints 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.2 Data Source 14.2 Author Details

List of Tables Table 1. Global Bile Duct Cancer Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of 5-fluorouracil Table 3. Key Players of Gemcitabine Table 4. Key Players of Cisplatin Table 5. Key Players of Other Table 6. Global Bile Duct Cancer Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 7. Global Bile Duct Cancer Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028 Table 8. Global Bile Duct Cancer Revenue by Region (2017-2022) & (US$ Million) Table 9. Global Bile Duct Cancer Revenue Market Share by Region (2017-2022) Table 10. Global Bile Duct Cancer Revenue by Players (2017-2022) & (US$ Million) Table 11. Global Bile Duct Cancer Market Share by Players (2017-2022) Table 12. Global Top Bile Duct Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bile Duct Cancer as of 2021) Table 13. Ranking of Global Top Bile Duct Cancer Companies by Revenue (US$ Million) in 2021 Table 14. Global 5 Largest Players Market Share by Bile Duct Cancer Revenue (CR5 and HHI) & (2017-2022) Table 15. Key Players Headquarters and Area Served Table 16. Key Players Bile Duct Cancer Product Solution and Service Table 17. Date of Key Manufacturers Enter into Bile Duct Cancer Market Table 18. Mergers & Acquisitions, Expansion Plans Table 19. Global Bile Duct Cancer Market Size by Type (2017-2022) & (US$ Million) Table 20. Global Bile Duct Cancer Revenue Market Share by Type (2017-2022) Table 21. Global Bile Duct Cancer Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 22. Global Bile Duct Cancer Revenue Market Share by Type (2023-2028) Table 23. Global Bile Duct Cancer Market Size by Application (2017-2022) & (US$ Million) Table 24. Global Bile Duct Cancer Revenue Market Share by Application (2017-2022) Table 25. Global Bile Duct Cancer Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 26. Global Bile Duct Cancer Revenue Market Share by Application (2023-2028) Table 27. North America Bile Duct Cancer Revenue by Company (2020-2022) & (US$ Million) Table 28. North America Bile Duct Cancer Revenue by Type (2017-2022) & (US$ Million) Table 29. North America Bile Duct Cancer Revenue by Type (2023-2028) & (US$ Million) Table 30. North America Bile Duct Cancer Revenue by Application (2017-2022) & (US$ Million) Table 31. North America Bile Duct Cancer Revenue by Application (2023-2028) & (US$ Million) Table 32. North America Bile Duct Cancer Revenue by Country (2017-2022) & (US$ Million) Table 33. North America Bile Duct Cancer Revenue by Country (2023-2028) & (US$ Million) Table 34. Europe Bile Duct Cancer Revenue by Company (2020-2022) & (US$ Million) Table 35. Europe Bile Duct Cancer Revenue by Type (2017-2022) & (US$ Million) Table 36. Europe Bile Duct Cancer Revenue by Type (2023-2028) & (US$ Million) Table 37. Europe Bile Duct Cancer Revenue by Application (2017-2022) & (US$ Million) Table 38. Europe Bile Duct Cancer Revenue by Application (2023-2028) & (US$ Million) Table 39. Europe Bile Duct Cancer Revenue by Country (2017-2022) & (US$ Million) Table 40. Europe Bile Duct Cancer Revenue by Country (2023-2028) & (US$ Million) Table 41. Asia Pacific Bile Duct Cancer Revenue by Company (2020-2022) & (US$ Million) Table 42. Asia Pacific Bile Duct Cancer Revenue by Type (2017-2022) & (US$ Million) Table 43. Asia Pacific Bile Duct Cancer Revenue by Type (2023-2028) & (US$ Million) Table 44. Asia Pacific Bile Duct Cancer Revenue by Application (2017-2022) & (US$ Million) Table 45. Asia Pacific Bile Duct Cancer Revenue by Application (2023-2028) & (US$ Million) Table 46. Asia Pacific Bile Duct Cancer Revenue by Region (2017-2022) & (US$ Million) Table 47. Asia Pacific Bile Duct Cancer Revenue by Region (2023-2028) & (US$ Million) Table 48. Latin America Bile Duct Cancer Revenue by Company (2020-2022) & (US$ Million) Table 49. Latin America Bile Duct Cancer Revenue by Type (2017-2022) & (US$ Million) Table 50. Latin America Bile Duct Cancer Revenue by Type (2023-2028) & (US$ Million) Table 51. Latin America Bile Duct Cancer Revenue by Application (2017-2022) & (US$ Million) Table 52. Latin America Bile Duct Cancer Revenue by Application (2023-2028) & (US$ Million) Table 53. Latin America Bile Duct Cancer Revenue by Country (2017-2022) & (US$ Million) Table 54. Latin America Bile Duct Cancer Revenue by Country (2023-2028) & (US$ Million) Table 55. Middle East and Africa Bile Duct Cancer Revenue by Company (2020-2022) & (US$ Million) Table 56. Middle East and Africa Bile Duct Cancer Revenue by Type (2017-2022) & (US$ Million) Table 57. Middle East and Africa Bile Duct Cancer Revenue by Type (2023-2028) & (US$ Million) Table 58. Middle East and Africa Bile Duct Cancer Revenue by Application (2017-2022) & (US$ Million) Table 59. Middle East and Africa Bile Duct Cancer Revenue by Application (2023-2028) & (US$ Million) Table 60. Middle East and Africa Bile Duct Cancer Revenue by Country (2017-2022) & (US$ Million) Table 61. Middle East and Africa Bile Duct Cancer Revenue by Country (2023-2028) & (US$ Million) Table 62. Pfizer Company Details Table 63. Pfizer Business Overview Table 64. Pfizer Bile Duct Cancer Product and Services Table 65. Pfizer Bile Duct Cancer Revenue in Bile Duct Cancer Business (2017-2022) & (US$ Million) Table 66. Pfizer Bile Duct Cancer SWOT Analysis Table 67. Pfizer Recent Developments Table 68. F. Hoffmann-La Roche Company Details Table 69. F. Hoffmann-La Roche Business Overview Table 70. F. Hoffmann-La Roche Bile Duct Cancer Product and Services Table 71. F. Hoffmann-La Roche Bile Duct Cancer Revenue in Bile Duct Cancer Business (2017-2022) & (US$ Million) Table 72. F. Hoffmann-La Roche Bile Duct Cancer SWOT Analysis Table 73. F. Hoffmann-La Roche Recent Developments Table 74. Bristol-Myers Squibb Company Details Table 75. Bristol-Myers Squibb Business Overview Table 76. Bristol-Myers Squibb Bile Duct Cancer Product and Services Table 77. Bristol-Myers Squibb Bile Duct Cancer Revenue in Bile Duct Cancer Business (2017-2022) & (US$ Million) Table 78. Bristol-Myers Squibb Bile Duct Cancer SWOT Analysis Table 79. Bristol-Myers Squibb Recent Developments Table 80. Teva Pharmaceutical Company Details Table 81. Teva Pharmaceutical Business Overview Table 82. Teva Pharmaceutical Bile Duct Cancer Product and Services Table 83. Teva Pharmaceutical Bile Duct Cancer Revenue in Bile Duct Cancer Business (2017-2022) & (US$ Million) Table 84. Teva Pharmaceutical Bile Duct Cancer SWOT Analysis Table 85. Teva Pharmaceutical Recent Developments Table 86. Eli Lilly and Company Company Details Table 87. Eli Lilly and Company Business Overview Table 88. Eli Lilly and Company Bile Duct Cancer Product and Services Table 89. Eli Lilly and Company Bile Duct Cancer Revenue in Bile Duct Cancer Business (2017-2022) & (US$ Million) Table 90. Eli Lilly and Company Bile Duct Cancer SWOT Analysis Table 91. Eli Lilly and Company Recent Developments Table 92. Sanofi Company Details Table 93. Sanofi Business Overview Table 94. Sanofi Bile Duct Cancer Product and Services Table 95. Sanofi Bile Duct Cancer Revenue in Bile Duct Cancer Business (2017-2022) & (US$ Million) Table 96. Sanofi Bile Duct Cancer SWOT Analysis Table 97. Sanofi Recent Developments Table 98. Fresenius Kabi Company Details Table 99. Fresenius Kabi Business Overview Table 100. Fresenius Kabi Bile Duct Cancer Product and Services Table 101. Fresenius Kabi Bile Duct Cancer Revenue in Bile Duct Cancer Business (2017-2022) & (US$ Million) Table 102. Fresenius Kabi Bile Duct Cancer SWOT Analysis Table 103. Fresenius Kabi Recent Developments Table 104. Mylan Company Details Table 105. Mylan Business Overview Table 106. Mylan Bile Duct Cancer Product and Services Table 107. Mylan Bile Duct Cancer Revenue in Bile Duct Cancer Business (2017-2022) & (US$ Million) Table 108. Mylan Bile Duct Cancer SWOT Analysis Table 109. Mylan Recent Developments Table 110. Bile Duct Cancer Market Trends Table 111. Bile Duct Cancer Market Drivers Table 112. Bile Duct Cancer Market Challenges Table 113. Bile Duct Cancer Market Restraints Table 114. Research Programs/Design for This Report Table 115. Key Data Information from Secondary Sources Table 116. Key Data Information from Primary Sources List of Figures Figure 1. Global Bile Duct Cancer Sales Market Share by Type: 2021 VS 2028 Figure 2. 5-fluorouracil Features Figure 3. Gemcitabine Features Figure 4. Cisplatin Features Figure 5. Other Features Figure 6. Global Bile Duct Cancer Sales Market Share by Application: 2021 VS 2028 Figure 7. Hospitals & Clinics Case Studies Figure 8. Other Case Studies Figure 9. Bile Duct Cancer Report Years Considered Figure 10. Global Bile Duct Cancer Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 11. Global Bile Duct Cancer Market Size 2017-2028 (US$ Million) Figure 12. Global Bile Duct Cancer Market Size Market Share by Region: 2021 VS 2028 Figure 13. Global Bile Duct Cancer Revenue Market Share by Region in 2017 VS 2022 Figure 14. Global Top 10 Bile Duct Cancer Countries Ranking by Market Size (US$ Million) in 2021 Figure 15. Global Bile Duct Cancer Market Share by Players in 2021 Figure 16. Global Top Bile Duct Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bile Duct Cancer as of 2021) Figure 17. The Top 10 and 5 Players Market Share by Bile Duct Cancer Revenue in 2021 Figure 18. North America Bile Duct Cancer Revenue Market Share by Company in 2021 Figure 19. North America Bile Duct Cancer Revenue Market Share by Type (2017-2028) Figure 20. North America Bile Duct Cancer Revenue Market Share by Application (2017-2028) Figure 21. North America Bile Duct Cancer Revenue Share by Country (2017-2028) Figure 22. U.S. Bile Duct Cancer Revenue (2017-2028) & (US$ Million) Figure 23. Canada Bile Duct Cancer Revenue (2017-2028) & (US$ Million) Figure 24. Europe Bile Duct Cancer Revenue Market Share by Company in 2021 Figure 25. Europe Bile Duct Cancer Revenue Market Share by Type (2017-2028) Figure 26. Europe Bile Duct Cancer Revenue Market Share by Application (2017-2028) Figure 27. Europe Bile Duct Cancer Revenue Share by Country (2017-2028) Figure 28. Germany Bile Duct Cancer Revenue (2017-2028) & (US$ Million) Figure 29. France Bile Duct Cancer Revenue (2017-2028) & (US$ Million) Figure 30. U.K. Bile Duct Cancer Revenue (2017-2028) & (US$ Million) Figure 31. Italy Bile Duct Cancer Revenue (2017-2028) & (US$ Million) Figure 32. Russia Bile Duct Cancer Revenue (2017-2028) & (US$ Million) Figure 33. Asia Pacific Bile Duct Cancer Revenue Market Share by Company in 2021 Figure 34. Asia Pacific Bile Duct Cancer Revenue Market Share by Type (2017-2028) Figure 35. Asia Pacific Bile Duct Cancer Revenue Market Share by Application (2017-2028) Figure 36. Asia Pacific Bile Duct Cancer Revenue Share by Region (2017-2028) Figure 37. China Bile Duct Cancer Revenue (2017-2028) & (US$ Million) Figure 38. Japan Bile Duct Cancer Revenue (2017-2028) & (US$ Million) Figure 39. South Korea Bile Duct Cancer Revenue (2017-2028) & (US$ Million) Figure 40. India Bile Duct Cancer Revenue (2017-2028) & (US$ Million) Figure 41. Australia Bile Duct Cancer Revenue (2017-2028) & (US$ Million) Figure 42. Taiwan Bile Duct Cancer Revenue (2017-2028) & (US$ Million) Figure 43. Indonesia Bile Duct Cancer Revenue (2017-2028) & (US$ Million) Figure 44. Thailand Bile Duct Cancer Revenue (2017-2028) & (US$ Million) Figure 45. Malaysia Bile Duct Cancer Revenue (2017-2028) & (US$ Million) Figure 46. Philippines Bile Duct Cancer Revenue (2017-2028) & (US$ Million) Figure 47. Vietnam Bile Duct Cancer Revenue (2017-2028) & (US$ Million) Figure 48. Latin America Bile Duct Cancer Revenue Market Share by Company in 2021 Figure 49. Latin America Bile Duct Cancer Revenue Market Share by Type (2017-2028) Figure 50. Latin America Bile Duct Cancer Revenue Market Share by Application (2017-2028) Figure 51. Latin America Bile Duct Cancer Revenue Share by Country (2017-2028) Figure 52. Mexico Bile Duct Cancer Revenue (2017-2028) & (US$ Million) Figure 53. Brazil Bile Duct Cancer Revenue (2017-2028) & (US$ Million) Figure 54. Argentina Bile Duct Cancer Revenue (2017-2028) & (US$ Million) Figure 55. Middle East and Africa Bile Duct Cancer Revenue Market Share by Company in 2021 Figure 56. Middle East and Africa Bile Duct Cancer Revenue Market Share by Type (2017-2028) Figure 57. Middle East and Africa Bile Duct Cancer Revenue Market Share by Application (2017-2028) Figure 58. Middle East and Africa Bile Duct Cancer Revenue Share by Country (2017-2028) Figure 59. Turkey Bile Duct Cancer Revenue (2017-2028) & (US$ Million) Figure 60. Saudi Arabia Bile Duct Cancer Revenue (2017-2028) & (US$ Million) Figure 61. U.A.E Bile Duct Cancer Revenue (2017-2028) & (US$ Million) Figure 62. Pfizer Revenue Growth Rate in Bile Duct Cancer Business (2017-2022) Figure 63. F. Hoffmann-La Roche Revenue Growth Rate in Bile Duct Cancer Business (2017-2022) Figure 64. Bristol-Myers Squibb Revenue Growth Rate in Bile Duct Cancer Business (2017-2022) Figure 65. Teva Pharmaceutical Revenue Growth Rate in Bile Duct Cancer Business (2017-2022) Figure 66. Eli Lilly and Company Revenue Growth Rate in Bile Duct Cancer Business (2017-2022) Figure 67. Sanofi Revenue Growth Rate in Bile Duct Cancer Business (2017-2022) Figure 68. Fresenius Kabi Revenue Growth Rate in Bile Duct Cancer Business (2017-2022) Figure 69. Mylan Revenue Growth Rate in Bile Duct Cancer Business (2017-2022) Figure 70. Bottom-up and Top-down Approaches for This Report Figure 71. Data Triangulation Figure 72. Key Executives Interviewed

Pfizer F. Hoffmann-La Roche Bristol-Myers Squibb Teva Pharmaceutical Eli Lilly and Company Sanofi Fresenius Kabi Mylan